BRIEF-Orbimed Advisors acquired 480,000 common shares of Cynapsus Therapeutics
July 7 (Reuters) - Orbimed Advisors Llc
* Acquired 480,000 common shares of cynapsus therapeutics inc
* Now collectively beneficially owns, controls and directs more than 10% of outstanding common shares of cynapsus
* Common shares were acquired at a price of us$13.00 per common share for total consideration paid of us$6.3 million Source text for Eikon: Further company coverage: )
© Thomson Reuters 2017 All rights reserved.